RILUTEK Side Effects

6021719-5 |
on Dec 19, 2008 Male patient from JAPAN , 71 years of age, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?), hypertension, constipation (What is constipation?), insomnia and was treated with Rilutek (View Usage). . Rilutek dosage: . During the same period patient was treated with RENIVACE (View Renivace Review and Renivace Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), BIOFERMIN (View Biofermin Review and Biofermin Label ), LOXONIN /00890701/ (View Loxonin /00890701/ Review and Loxonin /00890701/ Label ), GASTER D (View Gaster D Review and Gaster D Label ), MYSLEE (View Myslee Review and Myslee Label ), ROHYPNOL (View Rohypnol Review and Rohypnol Label ).

5973520-6 | Amyotrophic Lateral Sclerosis, Disease Progression
Patient was taking Rilutek (View Usage). Patient had the following side effects: amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?), disease progression on Nov 21, 2008 from CANADA Additional patient health information: Male patient , 67 years of age, . Rilutek dosage: .

5957978-4 | Electrocardiogram Qt Prolonged, Hypokalaemia
Adverse event was reported on Nov 11, 2008 by a Male patient taking Rilutek (View Usage) (Dosage: ) was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?), chronic obstructive pulmonary disease and. Location: ITALY , 51 years of age, After Rilutek was administered, patient had the following side effects: electrocardiogram qt prolonged, hypokalaemia. During the same period patient was treated with SELEPARINA /00889603/ (Dose: Unk) (View Seleparina /00889603/ Review and Seleparina /00889603/ Label ), LASITONE (Dose: Unk) (View Lasitone Review and Lasitone Label ), FUROSEMIDE (Dose: Unk) (View Furosemide Review and Furosemide Label ), ALPRAZOLAM (Dose: Unk) (View Alprazolam Review and Alprazolam Label ), FLUIMUCIL /00082801/ (View Fluimucil /00082801/ Review and Fluimucil /00082801/ Label ).

5952967-8 | Dyspnoea
on Nov 04, 2008 Male patient from CANADA , 67 years of age, was treated with Rilutek (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea. Rilutek dosage: .


5943044-0 | Condition Aggravated, Disease Progression, Pneumonia Aspiration
on Sep 16, 2008 Female patient from JAPAN , 70 years of age, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?), eating disorder (What is eating disorder?) and was treated with Rilutek (View Usage). Patient had the following side effects: condition aggravated, disease progression, pneumonia aspiration. Rilutek dosage: . During the same period patient was treated with PLETAL (View Pletal Review and Pletal Label ), METHYCOBAL /00056201/ (View Methycobal /00056201/ Review and Methycobal /00056201/ Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.

5937807-5 |
Patient was taking Rilutek (View Usage). on Oct 17, 2008 from CANADA Additional patient health information: Female patient , 67 years of age, . Rilutek dosage: Dose: Unk.

5929467-4 | Aphasia, Weight Decreased
Adverse event was reported on Oct 17, 2008 by a Male patient taking Rilutek (View Usage) (Dosage: ) was diagnosed with motor neurone disease and. Location: AUSTRALIA , 61 years of age, Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), weight decreased. During the same period patient was treated with ASPIRIN (Dose: Unk) (View Aspirin Review and Aspirin Label ), GLUCOSAMINE (Dose: Unk) (View Glucosamine Review and Glucosamine Label ), GINKGO (Dose: Unk) (View Ginkgo Review and Ginkgo Label ), PANADOL /00020001/ (Dose: Unk) (View Panadol /00020001/ Review and Panadol /00020001/ Label ). Patient was hospitalized.

5923333-6 | Electrocardiogram Qt Prolonged, Hypokalaemia
on Oct 08, 2008 Male patient from ITALY , 51 years of age, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and was treated with Rilutek (View Usage). Patient had the following side effects: electrocardiogram qt prolonged, hypokalaemia. Rilutek dosage: . During the same period patient was treated with SELEPARINA /00889603/ (Dose: Unk) (View Seleparina /00889603/ Review and Seleparina /00889603/ Label ), LASITONE (Dose: Unk) (View Lasitone Review and Lasitone Label ), FUROSEMIDE (Dose: Unk) (View Furosemide Review and Furosemide Label ), ALPRAZOLAM (Dose: Unk) (View Alprazolam Review and Alprazolam Label ), FLUIMUCIL /00082801/ (View Fluimucil /00082801/ Review and Fluimucil /00082801/ Label ).

5895480-9 | Urinary Tract Infection
on Sep 18, 2008 Male patient from JAPAN , 52 years of age, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and was treated with Rilutek (View Usage). After Rilutek was administered, patient had the following side effects: urinary tract infection (What is urinary tract infection?). Rilutek dosage: . During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), BREDININ (View Bredinin Review and Bredinin Label ), MEDROL (View Medrol Review and Medrol Label ), URINORM (View Urinorm Review and Urinorm Label ), BUFFERIN (View Bufferin Review and Bufferin Label ). Patient was hospitalized.

5887722-0 | Anorexia, Nausea, Weight Decreased
Patient was taking Rilutek (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, nausea (What is nausea?), weight decreased on Sep 08, 2008 from JAPAN Additional patient health information: Female patient , 39 years of age, weighting 143.3 lb, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and. Rilutek dosage: .

5869084-8 | Dyspnoea, Fall, Somnolence
Adverse event was reported on Aug 26, 2008 by a Male patient taking Rilutek (View Usage) (Dosage: ) . Location: AUSTRALIA , 58 years of age, Patient had the following side effects: dyspnoea, fall (What is fall?), somnolence. During the same period patient was treated with GLYCOPYRROLATE /00196201/ (Dose: Unk) (View Glycopyrrolate /00196201/ Review and Glycopyrrolate /00196201/ Label ). Patient was hospitalized.

5824267-8 | Dyspnoea, Fall, Somnolence
on Jul 17, 2008 Male patient from AUSTRALIA , 58 years of age, was treated with Rilutek (View Usage). After Rilutek was administered, patient had the following side effects: dyspnoea, fall (What is fall?), somnolence. Rilutek dosage: . Patient was hospitalized.

5803363-5 | Acute Respiratory Distress Syndrome, Dyspnoea, Hyperhidrosis, Interstitial Lung Disease, Pyrexia, Tremor, Vascular Purpura
on Jul 01, 2008 Male patient from , 72 years of age, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and was treated with Rilutek (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, dyspnoea, hyperhidrosis, interstitial lung disease, pyrexia, tremor, vascular purpura. Rilutek dosage: . During the same period patient was treated with DETENSIEL /00802601/ (View Detensiel /00802601/ Review and Detensiel /00802601/ Label ), KARDEGIC /00002703/ (View Kardegic /00002703/ Review and Kardegic /00002703/ Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ZESTRIL (View Zestril Review and Zestril Label ), ZYLORIC (View Zyloric Review and Zyloric Label ). Patient was hospitalized.

5793034-6 | Condition Aggravated, Motor Neurone Disease
Patient was taking Rilutek (View Usage). Patient had the following side effects: condition aggravated, motor neurone disease on Jun 23, 2008 from AUSTRALIA Additional patient health information: Male patient , 76 years of age, was diagnosed with motor neurone disease and. Rilutek dosage: Dose: Unk.

5780296-4 |
Adverse event was reported on Jun 13, 2008 by a Male patient taking Rilutek (View Usage) (Dosage: Dose: Unk) was diagnosed with motor neurone disease and. Location: , 76 years of age, .

5776548-4 | Acute Respiratory Distress Syndrome, Dyspnoea, Hyperhidrosis, Interstitial Lung Disease, Pyrexia, Tremor, Vascular Purpura
on Mar 27, 2008 Male patient from , 72 years of age, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and was treated with Rilutek (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, dyspnoea, hyperhidrosis, interstitial lung disease, pyrexia, tremor, vascular purpura. Rilutek dosage: . During the same period patient was treated with DETENSIEL /00802601/ (View Detensiel /00802601/ Review and Detensiel /00802601/ Label ), KARDEGIC /00002703/ (View Kardegic /00002703/ Review and Kardegic /00002703/ Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ZESTRIL (View Zestril Review and Zestril Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

5771470-1 | Condition Aggravated, Motor Neurone Disease
on Jun 06, 2008 Female patient from AUSTRALIA , 77 years of age, was diagnosed with motor neurone disease and was treated with Rilutek (View Usage). Patient had the following side effects: condition aggravated, motor neurone disease. Rilutek dosage: .

5758465-9 | Cerebral Haemorrhage, Coagulopathy, Gingival Bleeding, Thrombocytopenia
Patient was taking Rilutek (View Usage). After Rilutek was administered, patient had the following side effects: cerebral haemorrhage, coagulopathy, gingival bleeding, thrombocytopenia on May 23, 2008 from GERMANY Additional patient health information: Male patient , 62 years of age, weighting 147.7 lb, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and. Rilutek dosage: Dose: Not Reported.

5753556-0 | Dyspnoea, Panic Attack
Adverse event was reported on May 22, 2008 by a Male patient taking Rilutek (View Usage) (Dosage: ) . Location: AUSTRALIA , 70 years of age, Patient experienced the following unwanted or unexpected effects: dyspnoea, panic attack. Patient was hospitalized.

5744243-3 | Fall, Infection, Muscle Spasms
on May 13, 2008 Female patient from AUSTRALIA , 60 years of age, was treated with Rilutek (View Usage). Patient had the following side effects: fall (What is fall?), infection (What is infection?), muscle spasms. Rilutek dosage: . Patient was hospitalized.

5742615-4 |
on May 08, 2008 Female patient from AUSTRALIA , 77 years of age, was diagnosed with motor neurone disease and was treated with Rilutek (View Usage). . Rilutek dosage: .

5724947-9 | Asthenia
Patient was taking Rilutek (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia on Apr 30, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 136.0 lb, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and. Rilutek dosage: 50 Mg Twice Daily Po. During the same period patient was treated with PREMPRO (View Prempro Review and Prempro Label ).

5684385-4 | Dyspnoea, Panic Attack
Adverse event was reported on Mar 18, 2008 by a Male patient taking Rilutek (View Usage) (Dosage: ) . Location: AUSTRALIA , 70 years of age, Patient had the following side effects: dyspnoea, panic attack. Patient was hospitalized.

5668930-0 | Fall, Rib Fracture
on Mar 10, 2008 Male patient from AUSTRALIA , 81 years of age, was treated with Rilutek (View Usage). After Rilutek was administered, patient had the following side effects: fall (What is fall?), rib fracture. Rilutek dosage: . Patient was hospitalized.

5661356-5 | Fall, Infection, Muscle Spasms
on Mar 03, 2008 Female patient from AUSTRALIA , 60 years of age, was treated with Rilutek (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), infection (What is infection?), muscle spasms. Rilutek dosage: . Patient was hospitalized.

5659566-6 | Haematuria, International Normalised Ratio Increased
Patient was taking Rilutek (View Usage). Patient had the following side effects: haematuria, international normalised ratio increased on Feb 28, 2008 from Additional patient health information: Male patient , 73 years of age, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and. Rilutek dosage: . During the same period patient was treated with WARAN (Dose: Unk) (View Waran Review and Waran Label ), METOPROLOL TARTRATE (Dose: Unk) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), MADOPARK QUICK (Dose: Unk) (View Madopark Quick Review and Madopark Quick Label ), ZOLPIDEM TARTRATE (Dose: Unk) (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), SPARKAL MITE (Dose: Unk) (View Sparkal Mite Review and Sparkal Mite Label ), TIPAROL (Dose: Unk) (View Tiparol Review and Tiparol Label ). Patient was hospitalized.

5654769-9 | Blood Bilirubin Increased, Interstitial Lung Disease
Adverse event was reported on Feb 26, 2008 by a Female patient taking Rilutek (View Usage) (Dosage: ) was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and. Location: JAPAN , 65 years of age, weighting 99.21 lb, After Rilutek was administered, patient had the following side effects: blood bilirubin increased, interstitial lung disease.

5637217-4 | Cerebrovascular Accident
on Feb 18, 2008 Female patient from AUSTRALIA , 74 years of age, was treated with Rilutek (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident. Rilutek dosage: . During the same period patient was treated with DIAMICRON (Dose: Unk) (View Diamicron Review and Diamicron Label ), DIABEX (Dose: Unk) (View Diabex Review and Diabex Label ), ZOCOR (Dose: Unk) (View Zocor Review and Zocor Label ), EFEXOR /01233802/ (Dose: Unk) (View Efexor /01233802/ Review and Efexor /01233802/ Label ), COVERSYL /00790701/ (Dose: Unk) (View Coversyl /00790701/ Review and Coversyl /00790701/ Label ), ASTRIX (Dose: Unk) (View Astrix Review and Astrix Label ). Patient was hospitalized.

5632345-1 | Blood Bilirubin Increased, Interstitial Lung Disease
on Feb 13, 2008 Female patient from JAPAN , 65 years of age, weighting 99.21 lb, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and was treated with Rilutek (View Usage). Patient had the following side effects: blood bilirubin increased, interstitial lung disease. Rilutek dosage: .

5624832-7 | Pneumonia
Patient was taking Rilutek (View Usage). After Rilutek was administered, patient had the following side effects: pneumonia (What is pneumonia?) on Feb 07, 2008 from AUSTRALIA Additional patient health information: Male patient , 74 years of age, . Rilutek dosage: .

5624826-1 | Cerebrovascular Accident
Adverse event was reported on Feb 06, 2008 by a Female patient taking Rilutek (View Usage) (Dosage: ) . Location: AUSTRALIA , 74 years of age, Patient experienced the following unwanted or unexpected effects: cerebrovascular accident. During the same period patient was treated with DIAMICRON (Dose: Unk) (View Diamicron Review and Diamicron Label ), DIABEX (Dose: Unk) (View Diabex Review and Diabex Label ), ZOCOR (Dose: Unk) (View Zocor Review and Zocor Label ), EFEXOR /01233802/ (Dose: Unk) (View Efexor /01233802/ Review and Efexor /01233802/ Label ), COVERSYL /00790701/ (Dose: Unk) (View Coversyl /00790701/ Review and Coversyl /00790701/ Label ), ASTRIX (Dose: Unk) (View Astrix Review and Astrix Label ). Patient was hospitalized.

5623996-9 | Pneumonia
on Feb 08, 2008 Female patient from UNITED STATES , weighting 14.11 lb, was diagnosed with spinal muscular atrophy (What is spinal muscular atrophy?) and was treated with Rilutek (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?). Rilutek dosage: 35 Mg Daily Po. Patient was hospitalized.

5623995-7 | Respiratory Disorder
on Feb 08, 2008 Female patient from UNITED STATES , weighting 18.96 lb, was diagnosed with spinal muscular atrophy (What is spinal muscular atrophy?) and was treated with Rilutek (View Usage). After Rilutek was administered, patient had the following side effects: respiratory disorder. Rilutek dosage: 50mg Daily 25mg Am + Pm Po. During the same period patient was treated with TYLENOL SUSPENSION (View Tylenol Suspension Review and Tylenol Suspension Label ). Patient was hospitalized.

5623989-1 | No Adverse Event
Patient was taking Rilutek (View Usage). Patient experienced the following unwanted or unexpected effects: no adverse event on Feb 08, 2008 from UNITED STATES Additional patient health information: Female patient , child 1 years of age, was diagnosed with spinal muscular atrophy (What is spinal muscular atrophy?) and. Rilutek dosage: . Patient was hospitalized.

5623988-X | No Adverse Event
Adverse event was reported on Feb 08, 2008 by a Female patient taking Rilutek (View Usage) (Dosage: ) was diagnosed with spinal muscular atrophy (What is spinal muscular atrophy?) and. Location: UNITED STATES , child 1 years of age, Patient had the following side effects: no adverse event. Patient was hospitalized.

5623972-6 | Viral Infection
on Feb 08, 2008 Male patient from UNITED STATES , weighting 15.43 lb, was diagnosed with spinal muscular atrophy (What is spinal muscular atrophy?) and was treated with Rilutek (View Usage). After Rilutek was administered, patient had the following side effects: viral infection (What is viral infection?). Rilutek dosage: . During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), D ALLERGY (View D-allergy Review and D-allergy Label ). Patient was hospitalized.

5598293-0 | Pneumonia
on Jan 15, 2008 Male patient from JAPAN , 71 years of age, was treated with Rilutek (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?). Rilutek dosage: .

5574843-5 | Cough, Dyspnoea, Hepatitis
Patient was taking Rilutek (View Usage). Patient had the following side effects: cough, dyspnoea, hepatitis (What is hepatitis?) on Dec 21, 2007 from UNITED STATES Additional patient health information: Male patient , 76 years of age, weighting 175.0 lb, . Rilutek dosage: . Patient was hospitalized.

5570907-0 | Ileus
Adverse event was reported on Dec 11, 2007 by a Female patient taking Rilutek (View Usage) (Dosage: Dose: Unk) . Location: UNITED STATES , 57 years of age, After Rilutek was administered, patient had the following side effects: ileus. During the same period patient was treated with BACLOFEN (Dose: Unk) (View Baclofen Review and Baclofen Label ), NEURONTIN (Dose: Unk) (View Neurontin Review and Neurontin Label ), TRAZODONE HCL (Dose: Unk) (View Trazodone Hcl Review and Trazodone Hcl Label ), CYMBALTA (Dose: Unk) (View Cymbalta Review and Cymbalta Label ), PHENERGAN HCL (Dose: Unk) (View Phenergan Hcl Review and Phenergan Hcl Label ).

5545632-2 | Cerebrovascular Accident
on Dec 03, 2007 Female patient from AUSTRALIA , 74 years of age, was treated with Rilutek (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident. Rilutek dosage: . During the same period patient was treated with DIAMICRON (Dose: Unk) (View Diamicron Review and Diamicron Label ), DIABEX (Dose: Unk) (View Diabex Review and Diabex Label ), ZOCOR (Dose: Unk) (View Zocor Review and Zocor Label ), EFEXOR /01233802/ (Dose: Unk) (View Efexor /01233802/ Review and Efexor /01233802/ Label ), COVERSYL /00790701/ (Dose: Unk) (View Coversyl /00790701/ Review and Coversyl /00790701/ Label ), ASTRIX (Dose: Unk) (View Astrix Review and Astrix Label ).

5525859-6 | Cerebrovascular Accident
on Nov 16, 2007 Female patient from AUSTRALIA , 74 years of age, was treated with Rilutek (View Usage). Patient had the following side effects: cerebrovascular accident. Rilutek dosage: .

5499202-5 | Fatigue, Nausea
Patient was taking Rilutek (View Usage). After Rilutek was administered, patient had the following side effects: fatigue, nausea (What is nausea?) on Oct 22, 2007 from AUSTRALIA Additional patient health information: Female patient , 63 years of age, was diagnosed with motor neurone disease and. Rilutek dosage: Dose: Unk.

5499199-8 | Myocardial Infarction
Adverse event was reported on Oct 17, 2007 by a Male patient taking Rilutek (View Usage) (Dosage: ) was diagnosed with motor neurone disease and. Location: AUSTRALIA , 79 years of age, Patient experienced the following unwanted or unexpected effects: myocardial infarction. During the same period patient was treated with ESOMEPRAZOLE (Dose: Unk) (View Esomeprazole Review and Esomeprazole Label ), RISEDRONATE SODIUM (Dose: Unk) (View Risedronate Sodium Review and Risedronate Sodium Label ), IRBESARTAN (Dose: Unk) (View Irbesartan Review and Irbesartan Label ), ATORVASTATIN (Dose: Unk) (View Atorvastatin Review and Atorvastatin Label ), METOPROLOL (Dose: Unk) (View Metoprolol Review and Metoprolol Label ), ALLOPURINOL (Dose: Unk) (View Allopurinol Review and Allopurinol Label ).

5499197-4 |
on Oct 22, 2007 Male patient from , 64 years of age, was treated with Rilutek (View Usage). . Rilutek dosage: .

5481366-0 | Fatigue, Multiple Fractures, Nausea
on Sep 27, 2007 Female patient from AUSTRALIA , 63 years of age, was diagnosed with motor neurone disease and was treated with Rilutek (View Usage). After Rilutek was administered, patient had the following side effects: fatigue, multiple fractures, nausea (What is nausea?). Rilutek dosage: Dose: Unk. Patient was hospitalized.

5465898-7 | Myocardial Infarction
Patient was taking Rilutek (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction on Sep 14, 2007 from AUSTRALIA Additional patient health information: Male patient , 79 years of age, was diagnosed with motor neurone disease and. Rilutek dosage: .

5464462-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Blood Urea Increased, Gamma-glutamyltransferase Increased, Liver Disorder, Malaise, Myalgia, Proteinuria
Adverse event was reported on Sep 18, 2007 by a Male patient taking Rilutek (View Usage) (Dosage: ) was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and. Location: JAPAN , 57 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood urea increased, gamma-glutamyltransferase increased, liver disorder, malaise, myalgia, proteinuria. During the same period patient was treated with PL GRAN. (View Pl Gran. Review and Pl Gran. Label ). Patient was hospitalized.

5412112-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Blood Urea Increased, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal, Malaise, Myalgia, Proteinuria
on Aug 07, 2007 Male patient from JAPAN , 57 years of age, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and was treated with Rilutek (View Usage). After Rilutek was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood urea increased, gamma-glutamyltransferase increased, hepatic function abnormal, malaise, myalgia, proteinuria. Rilutek dosage: . During the same period patient was treated with PL GRAN. (View Pl Gran. Review and Pl Gran. Label ). Patient was hospitalized.

5412111-2 | Blood Bilirubin Increased, Interstitial Lung Disease
on Aug 07, 2007 Female patient from JAPAN , 65 years of age, weighting 100.5 lb, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) and was treated with Rilutek (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin increased, interstitial lung disease. Rilutek dosage: .

5412106-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Pneumonia Aspiration
Patient was taking Rilutek (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, pneumonia aspiration on Aug 08, 2007 from JAPAN Additional patient health information: Male patient , 63 years of age, was diagnosed with amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?), nervous system disorder and. Rilutek dosage: . During the same period patient was treated with JUVELA NICOTINATE (View Juvela Nicotinate Review and Juvela Nicotinate Label ), METHYCOBAL /00056201/ (View Methycobal /00056201/ Review and Methycobal /00056201/ Label ), ALLEGRA (View Allegra Review and Allegra Label ), VITAMIN B NOS (View Vitamin B Nos Review and Vitamin B Nos Label ), COMBINATIONS OF VITAMINS (View Combinations Of Vitamins Review and Combinations Of Vitamins Label ), DEPAS (View Depas Review and Depas Label ). Patient was hospitalized.